In this study, we demonstrated that the combination of CB1 agonist (ACEA) and CB2 agonist (GW405833) at 2:1 ratio also provided the long-term inhibitory effect on breast cancer colony formation even after treatment withdrawal. The gene discussed is CNR1; the disease is breast carcinoma.